Hyperguides

Ophthalmology / Cornea & anterior segment

Current Concepts in the Management of Recurrent Corneal Erosions

Renée Solomon, MD · Henry D. Perry, MD · Eric D. Donnenfeld, MD
Article

Renée Solomon, MD · Henry D. Perry, MD · Eric D. Donnenfeld, MD

None of the authors has a proprietary or financial interest in any material or method mentioned.

Etiology and Symptoms


SLIDE 1

SLIDE 2
The primary clinical etiology of recurrent corneal erosions or recurrent erosion syndrome include epithelial dystrophies (map dot fingerprint dystrophy, also known as epithelial basement membrane dystrophy or Cogan microcystic dystrophy) (Slide 1, Slide 2), Meesmann's dystrophy (hereditary juvenile epithelial dystrophy), Bowman's membrane dystrophy (Reis-Bücklers I and II), and stromal dystrophies (macular, lattice, or granular dystrophies).

Secondary clinical etiologies include organic mechanical trauma (fingernails, paper), surgery, miscellaneous disorders (diabetes, dermatological diseases) or chronic corneal edema, from pseudophakic bullous keratopathy or Fuchs' dystrophy, in which there is abnormally reduced adhesion of the epithelium to the basement membrane and Bowman's membrane.1

Refractive surgery including laser in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) can induce or precipitate symptoms of recurrent corneal erosions.2-3 Surgeons must minimize epithelial damage to prevent recurrent corneal erosions after LASIK. Adequate irrigation of the corneal surface immediately before the microkeratome pass and careful attention to flap epithelium during flap replacement reduce epithelial damage.2

Symptoms suggestive of mild recurrent erosions after refractive surgery include sharp pains, the sensation of the eyelid's sticking to the eyeball, and soreness of the eyelid to touch, the latter a previously unrecognized symptom of this condition. These symptoms occurred commonly after excimer laser procedures but were significantly more common, more severe, and more prolonged after PRK.3 We believe LASIK should be avoided in patients with epithelial basement membrane dystrophy.

The injury secondary to corneal trauma usually heals quickly without evidence of damage. However, it is well known that injuries associated with carbon-based moieties such as a child's fingernail


SLIDE 3

SLIDE 4
or a paper cut will more likely lead to recurrent erosions than a metallic injury that invariably heals without sequelae.

The increased risk of development of recurrent erosion syndrome after injuries associated with carbon moieties relates to the disturbance of the stereochemistry of the anchoring fibrils and the basement membrane of the basal epithelial cells. Approximately half of the patients with recurrent corneal erosions have map-dot fingerprint dystrophy, while 10% of patients with anterior basement dystrophy have recurrent corneal erosions.

Contributing factors to recurrent erosions include dry eyes, blepharitis, external disease, and tear film abnormalities (Slide 3). The pathophysiology of recurrent

SLIDE 5

SLIDE 6
erosions include basal epithelial membrane misdirection, which results in a thickened basement membrane, reduplicated basement membrane, intraepithelial pseudocysts, and lack of hemidesmosomes (Slide 4, Slide 5, Slide 6, Slide 7, Slide 8).4

Activity of gelatinase (MMP-2 and MMP-9) is upregulated in corneal epithelial specimens of patients with recurrent corneal erosions.5-6 During wound healing, the epithelial basement membrane is altered by gelatinases, which cleave collagen types IV, V, VII and X.5,6

Immunolocalization studies suggest that MMP-2 is concentrated in basal epithelial cells where it may play an important role in degradation of the epithelial

SLIDE 7

SLIDE 8
anchoring system and the recurrent epithelial slippage and erosion observed in patients.6 Medications that inhibit metalloproteinase-9 produce rapid resolution and prevent further recurrence of recalcitrant recurrent corneal erosions.5-7 Studies are underway to characterize the effect of changes in alpha 9 integrin expression during wound healing and its effect on recurrent corneal erosions.8

Symptoms of recurrent corneal erosions include the acute onset of nocturnal pain, pain on awakening, accompanied by photophobia, lacrimation, and conjunctival injection. Extent and severity vary with the individual episodes. There may be a history of similar episodes in the same eye.

Slit Lamp Examination

During an acute attack, signs on slip lamp examination may show increased areas of epithelium in the involved area. Although no epithelial defect may be present, pooling of fluorescein over the affected area may be noted. In addition, slit lamp examination using retroillumination may demonstrate subtle corneal irregularities.

Careful examination of the contralateral eye may aid in the distinction between post-traumatic erosion and dystrophic erosion in a patient who has no evidence or history of superficial trauma.

Medical and Surgical Management of Recurrent Erosions

Ocular lubricants are the standard treatment for recurrent corneal erosion. Loose flaps of epithelium should be removed before prescribing lubricants. In some dystrophic cases, reduplicated basement membrane can be scraped off before lubricant treatment is resumed. In some patients, pressure patching may decrease the pain. Loose corneal epithelium that impedes healing should be debrided.

After the episode subsides, lubrication such as artificial tears and artificial tear ointment may be applied to prevent mechanical epithelial trauma from the eyelids. Lubrication should be continued for 3 to 6 months after an erosion.

Hypertonic saline (5% sodium chloride) drops or ointment may be applied if a patient has a recurrence while using artificial tears and ointment. Hypertonic agents may transiently produce an osmotic gradient, drawing fluid from the epithelium, and may promote the adherence of epithelial cells to the underlying tissue. Brown and Bron9 reported the benefit of using long-term topical 5% NaCl ointment (18 months) for clinical improvement in patients with recurrent erosions.

Where these measures fail, other treatment modalities may be used including application of a therapeutic contact lens, or more invasive procedures such as anterior stromal puncture, diamond burr polishing, superficial scraping with a Bard-Parker blade (Becton Dickinson, AcuteCare, Franklin Lakes, NJ) or a 57 Beaver blade (Becton Dickinson, AcuteCare, Franklin Lakes, NJ), and excimer laser phototherapeutic keratectomy (PTK).10

The choice of treatment may be affected by:

  • Etiology
  • Location of disease (axial or off-axis)
  • Coexisting ocular diseases
  • Individual patient reliability
  • Availability of equipment

The therapeutic contact lens has a role in the management of difficult post-traumatic cases in which the lesion is axial. The use of such a lens in dystrophic cases is often not effective, and these cases may be most effectively treated with PTK. If a contact lens is used, then the lens should be fit tight and the physician and patient should be aware of the risk of microbial keratitis. The ideal lens should have a flat base curve and high oxygen transmissibility (Dk).11-14

In patients with recurrent corneal erosions who were unresponsive to conventional medical therapies, therapy with a combination of medications that inhibit metalloproteinase-9 produced

SLIDE 9

SLIDE 10
rapid resolution and prevented further recurrence of recurrent corneal erosions.5-7

With corneal erosions recalcitrant to all medical therapies, aggressive intervention may be necessary. Anterior stromal micropuncture may be indicated in patients with recurrent erosions secondary to trauma.15

The ophthalmologist uses a 25-gauge needle to make superficial puncture wounds in the involved area (Slide 9, Slide 10, Slide 11).15 These wounds produce a firm adhesion between the epithelium and the underlying stroma.

In patients who have a basement membrane disorder, epithelial debridement is the recommended procedure. After application of topical anesthetic,

SLIDE 11

SLIDE 12
loosely adherent epithelium is debrided using a 57 Beaver blade until a healthy edge of adherent epithelium is encountered being careful not to damage the underlying Bowman's layer (Slide 12).

After debridement, a patient is prescribed topical antibiotics, cycloplegic drops, and bandage contact lenses until re-epithelialzation has occurred. A large diamond burr can be used to polish Bowman's membrane after debridement. This method cleans Bowman's membrane resulting in a fresh substrate onto which the epithelium can regrow and create attachment complexes.

Excimer laser PTK has been shown to be beneficial for the management of epithelial dystrophies and recurrent erosions.16-18 PTK is

SLIDE 13

SLIDE 14
effective for the treatment for recurrent erosions occurring in the setting of epithelial basement membrane disease, is well tolerated, and may improve visual acuity.18 This technique involves debridement of all loose epithelium followed by a superficial PTK of Bowman's membrane (Slide 13, Slide 14).

This technique permits the precise removal of adherent abnormal basement membrane and allows new epithelium to adhere on fresh substrate. The minimal ablation depth usually results in an insignificant refractive shift. However, in myopic patients, PTK may be combined with PRK. The rate of recurrence of erosions in epithelial basement membrane disease treated with PTK is low during a 12-month follow-up period19 and repeat PTK has been shown to be effective for repeat episodes.19

Evaluation of corneal topography, including the surface regularity index (SRI) and surface asymmetry index (SAI) may aid in choosing the appropriate management of recurrent corneal erosions. The SRI is calculated from a summation of local power fluctuations along 256 equally spaced meridians. The SRI rises with increasing irregular astigmatism and approaches zero for a smooth corneal surface. The SRI shows local fluctuations in corneal power.

The SAI is a centrally weighted summation of differences in corneal power between corresponding points 180° apart on 128 equally spaced meridians. The SAI approaches zero for a perfectly radially symmetrical surface and increases as the corneal shape becomes more asymmetrical.20

Evidence of an irregular topography suggests a corneal scraping so that the epithelium has a chance to grow back and smooth out the surface. Significant improvement in topography and vision may be seen after epithelial scraping. Evidence of a regular topography would be an indication for an anterior stromal puncture rather than a corneal scraping.

Summary

Recurrent corneal erosions may be difficult to treat, recalcitrant, and chronic. Many options for treatment are available ranging from artificial tear lubrication and bandage contact lenses to more aggressive management including anterior stromal puncture and PTK. Further research in this area is necessary to develop prophylaxis against future episodes of recurrent erosions in patients.

References

  1. Reidy JJ, Paulus MP, Gona S. Recurrent erosions of the cornea: Epidemiology and treatment. Cornea. 2000;19:767-771.
  2. Ti SE, Tan DT. Recurrent corneal erosion after laser in situ keratomileusis. Cornea. 2001;20:156-158.
  3. Hovanesian JA, Shah SS, Maloney RK. Symptoms of dry eye and recurrent erosion syndrome after refractive surgery. J Cataract Refract Surg. 2001:27:577-584.
  4. Rodriguez MM, Fein BS, Laibson PR, et al. A clinical pathologic study of dot, geographic, and fingerprint patterns. Arch Ophthalmol. 1974;92:475-482.
  5. Dursun D, Kim MC, Solomon A, Pflugfelder SC. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. 2001;132:8-13.
  6. Pal-Ghosh S, Pajoohesh-Ganji A, Brown M, Stepp MA. A mouse model for the study of recurrent corneal epithelial erosions: alpha9beta1 integrin implicated in progression of the disease. Invest Ophthalmol Vis Sci. 2004;45:1775-1788.
  7. Perry HD, Kenyon, KR, Lamberts DW, et al. Systemic tetracycline hydrochloride as adjunctive therapy in the treatment of persistent epithelial defects. Ophthalmology. 1986;10:1320-1322.
  8. Garrana RM, Zieske JD, Assouline M, Gipson IK. Matrix metalloproteinases in epithelia from human recurrent corneal erosion. Invest Ophthalmol Vis Sci. 1999;40:1266-1270.
  9. Brown N, Bron A. Recurrent erosion of the cornea. Br J Ophthalmol. 1976;60:84-96.
  10. Ardjomand N, Fellner P, Vidic B. Phototherapeutic keratectomy with an epithelial flap for recurrent erosion syndrome. J Cataract Refract Surg. 2004;30:543-545.
  11. Kanpolat A, Ucakhan OO. Therapeutic use of Focus Night & Day contact lenses. Cornea. 2003;22:726-734.
  12. Montero J, Sparholt J, Mely R. Retrospective case series of therapeutic applications of a lotrafilcon A silicone hydrogel soft contact lens. Eye Contact Lens. 2003;29(Suppl):S54-S56; discussion S57-S59, S192-S194.
  13. Montero J, Sparholt J, Mely R, Long B. Retrospective case series of therapeutic applications of lotrafilcon a silicone hydrogel soft contact lenses. Eye Contact Lens. 2003;29:72-75.
  14. Liu C, Buckley R. The role of the therapeutic contact lens in the management of recurrent corneal erosions: A review of treatment strategies. CLAO J. 1996;22:79-82.
  15. McLean EN, Macrae SM, Rich LF. Recurrent Erosion: Treatment by anterior stromal puncture. Ophthalmology. 1986;93:784-788.
  16. Starr M, Donnenfeld E, Newton M, et al. Excimer laser phototherapeutic keratectomy. Cornea. 1996;15:557-565.
  17. Jain S, Austin DJ. Phototherapeutic keratectomy for treatment of recurrent corneal erosion. J Cataract Refract Surg. 1999;25:1610-1614.
  18. Cavanaugh TB, Lind DM, Cutarelli PE, et al. Phototherapeutic keratectomy for recurrent erosion syndrome in anterior basement membrane dystrophy. Ophthalmology. 1999;106:971-976.
  19. Maini R, Loughnan MS. Phototherapeutic keratectomy re-treatment for recurrent corneal erosion syndrome. Br J Ophthalmol. 2002;86:270-272.
  20. Donnenfeld ED, Kanellopoulos AJ, Perry HD. Diagnosis and management of epithelial basement membrane dystrophy based on topographic analysis. Presented at the American Academy of Ophthalmology, 1995.